Cellulitis
Conditions
Brief summary
This is a randomized, controlled study to compare patients evaluated and managed by internal medicine hospitalists alone versus patients who are additionally evaluated by a dermatologist when they are admitted to the hospital, aiming to demonstrate that hospital admissions for cellulitis that involve early dermatology consultation will reduce hospital length of stay, readmission rates, prevalence of pseudocellulitis, cost, and antibiotic usage. The hypothesis of this study is that obtaining inpatient dermatology consultations, within 24 hours of a patient being admitted to the hospital for cellulitis, will reduce the length of stay, readmission rate, cost, and antibiotic usage of the patient"s admission as well as properly evaluate and diagnose patients with pseudocellulitis. The primary objective will be to measure the difference in the length of stay for patients who are randomized to a dermatology consultation within 24 hours of hospital admission (active arm) versus being managed by an internal medicine hospitalist alone, as is the standard of care (control arm). The length of stay for each arm will be assessed once the study has been completed. The secondary endpoint will be to measure readmission rates for cellulitis after patients are discharged from the hospital. An additional endpoint will be to determine if antibiotic usage differs between patients randomized to a dermatology consultation and those not. Exploratory analyses will assess the percentage of patients with a concomitant known predisposing factor for recurrent cellulitis such as lymphedema, leg ulceration, tinea pedis, or onychomycosis, as well as the association of fever \>100.5 F and a history of a prior episode of cellulitis.
Interventions
OTHERDermatology consult
Sponsors
Massachusetts General Hospital
Dermatology Foundation
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Able to understand and sign informed consent * Able to complete study and comply with study procedures * Presumed clinical diagnosis of cellulitis by medicine team
Exclusion criteria
* Have a known postoperative site infection or abscess * Have a human/animal bite * Have known osteomyelitis * Have a hardware/line infection * Are under the age of 18 * Have a history of transplantation less than six months after initial transplant and/or if they have had an episode of acute rejection in the last 90 days * Known use of antithymocyte globulin or campath in the last 6 months or more than 20 mg/day of prednisone for more than 30 days - * Are a known prisoner. * Are decisionally-impaired. * Have abnormal vital signs defined as systolic blood pressure \<90 mmHg, diastolic blood pressure \<80 mmHg, heart rate greater than 90 beats per minute or less than 50 beats per minute, respiratory rate greater than 20, or temperature \> 100.5 F. * Are known to be pregnant.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Antibiotic usage | 2 weeks after discharge from hospital stay | We will be measuring the difference between antibiotic usage in patients in the control group as compared with the treatment group |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Length of hospital stay | Will be measured at day of patient discharge | We will be comparing the length of admission between the control group and the treatment group to assess whether a dermatology consult has any impact on the length of a patient's hospital stay. |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORDaniela Kroshinsky, MD
Massachusetts General Hospital
Outcome results
None listed